These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8283365)

  • 1. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.
    Guinan EC; Lopez KD; Huhn RD; Felser JM; Nathan DG
    J Pediatr; 1994 Jan; 124(1):144-50. PubMed ID: 8283365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C; Guinan E
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R; Talpaz M; Gutterman JU
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.
    Lopez KD; Guinan EC
    Pediatr Nurs; 1995; 21(4):345-9. PubMed ID: 7644282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients.
    Kurzrock R; Talpaz M; Gomez JA; Estey EH; O'Brien S; Hirsch-Ginsberg C; Koller C; Freireich EJ; Gutterman JU
    Br J Haematol; 1991 Jul; 78(3):352-8. PubMed ID: 1873220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.
    Rackoff WR; Orazi A; Robinson CA; Cooper RJ; Alter BP; Freedman MH; Harris RE; Williams DA
    Blood; 1996 Sep; 88(5):1588-93. PubMed ID: 8781414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
    Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
    J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF in the treatment of Fanconi's anaemia.
    Kemahli S; Canatan D; Uysal Z; Akar N; Cin S; Arcasoy A
    Br J Haematol; 1994 Aug; 87(4):871-2. PubMed ID: 7986733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Diamond-Blackfan anaemia with haematopoietic growth factors, granulocyte-macrophage colony stimulating factor and interleukin 3: sustained remissions following IL-3.
    Dunbar CE; Smith DA; Kimball J; Garrison L; Nienhuis AW; Young NS
    Br J Haematol; 1991 Oct; 79(2):316-21. PubMed ID: 1958491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
    N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.
    Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
    J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
    Hattori K; Orita T; Oheda M; Tamura M; Ono M
    In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin.
    Erduran E; Hacisalihoglu S; Ozoran Y
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):333-5. PubMed ID: 12679652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of hematopoietic growth factors (G-CSF and GM-CSF) in the treatment of chemotherapy-induced or idiopathic bone marrow failure.
    Robak T; Krykowski E; Warzocha K; Kończalik P
    Acta Haematol Pol; 1993; 24(3):253-62. PubMed ID: 7504385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.
    Scagni P; Saracco P; Timeus F; Farinasso L; Dall'Aglio M; Bosa EM; Crescenzio N; Spinelli M; Basso G; Ramenghi U
    Haematologica; 1998 May; 83(5):432-7. PubMed ID: 9658728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.